ArticleInvestigational new drugs2023

Prognosis prediction of icotinib as targeted therapy for advanced EGFR-positive non-small cell lung cancer patients.

Xueyun Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.